Pharmacotherapy from Pre-COVID to Post-COVID: Longitudinal Trends and Predictive Indicators for Long COVID Symptoms
Our findings provide longitudinal, descriptive pharmacotherapy insights and suggest that medication history can be a valuable health status indicator in characterizing patients for personalized disease management strategies, considering the heterogeneous nature of long COVID.
Authors
- Merel E. B. Cornelissen (ORCID: https://orcid.org/0009-0004-5707-4673)
- Anke H. Maitland‐van der Zee (ORCID: https://orcid.org/0000-0002-0414-3442)
- Sien T. Verbeek
- Jos W. R. Twisk (ORCID: https://orcid.org/0000-0001-9617-1020)
- Harm Jan Bogaard (ORCID: https://orcid.org/0000-0001-5371-0346)
- Nadia Baalbaki (ORCID: https://orcid.org/0000-0002-8188-7760)
- Jelle M. Blankestijn (ORCID: https://orcid.org/0009-0006-2047-0888)
- Korneliusz Golebski (ORCID: https://orcid.org/0000-0002-4685-4592)
- Vera C. van den Brink (ORCID: https://orcid.org/0009-0005-9697-2940)
Institutions
- GGD Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3390/biomedicines12122694
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.37